Brief: Bioadaptives Signs Non-Exclusive License With Ly Research To Market Patented Bioavailable Resveratrol For Both Animals And Humans
18/04/2023 13:07
April 18 (Reuters) - BioAdaptives Inc BDPT.PK :
* BIOADAPTIVES SIGNS NON-EXCLUSIVE LICENSE WITH LY RESEARCH
TO
MARKET PATENTED BIOAVAILABLE RESVERATROL FOR BOTH ANIMALS AND
HUMANS
Source text for Eikon: ID:nGNX6jvF6x
Further company coverage: BDPT.PK
Recent news on BioAdaptives
See all newsBrief: Bioadaptives Says Successful Completion Of Dosage Trials For Its Innovative Weight Loss Product, Zeranovia
Brief: BioAdaptives Announces Spin-off LiveStock Impact Division as Wholly Owned Subsidiary
Brief: Bioadaptives Inc Announces Intention To Spin Off Its Livestock Impact Division As A Wholly-Owned Subsidiary
Brief: Bioadaptives Signs Non-Exclusive License With Ly Research To Market Patented Bioavailable Resveratrol For Both Animals And Humans
Brief: Bioadaptives Inc. Reports New Appointment To The Board Of Directors - Visionary Futurist , Wellness Pioneer And Marketer, David Allen, Phd